FTEC CAPITAL · BOUTIQUE ADVISORY
FTEC Capital advises healthcare and AI-for-science companies on pivotal financing, equity, M&A and BD transactions with research-led judgement and disciplined execution.
About FTEC
FTEC Capital is a boutique investment banking and financial advisory firm focused on healthcare and AI for science. We believe pivotal transactions are not merely matched; they are shaped by industry judgement, capital strategy and disciplined execution.
FTEC stands for Filter, Transition and Evolution — a philosophy of selecting signal, shaping transformation and compounding enterprise value.
Capabilities
Research-led judgement and execution discipline across financing, equity transactions, M&A and BD / licensing.
From equity story and materials to investor targeting and negotiation, we help companies complete high-quality private financings.
We structure secondary and strategic equity transactions that balance pricing, shareholder alignment and long-term value.
We design transaction pathways between buyers and sellers, from target screening and valuation to negotiation and capital-market follow-through.
We support product rights, upstream / downstream partnerships and cross-border BD transactions from counterparty search to commercial terms.
Sector focus
We focus on sectors where interdisciplinary judgement and capital-market articulation matter most.
Coverage across innovative therapeutics, medical devices, diagnostics, life-science tools, digital health and healthcare services.
Focused on AI-enabled drug discovery, protein design, R&D automation, scientific infrastructure and productivity transformation.
Selected transactions
No transaction amounts, confidential client details, unverified attribution, investor coverage statistics or logo walls are displayed.
Supported financing around clinical value and commercialization pathway.
Precision medicine
Advised on capital narrative and institutional engagement for an AI4S company.
AI drug discovery
Helped articulate product value, market opportunity and financing process.
Medical devices
Supported capital-market communication around innovative pipeline and clinical milestones.
Innovative therapeutics
Participated in financing advisory for a diagnostics company.
Diagnostics and digital pathology
Team
Team profiles are summarized from existing company materials and limited to public-ready biographies.
Founding Partner
More than ten years of experience across public-market sector research and private-market investment banking. Led or participated in multiple healthcare and hard-tech financing mandates. B.S. in Pharmacy, Shanghai Jiao Tong University.
Managing Partner
Over ten years of consulting, private-market investment and financing experience, with focus on TMT, advanced manufacturing, medical devices and consumer healthcare, plus early-stage incubation and operating experience.
Partner
Nearly a decade of biologics development experience, spanning antibody drugs, cell therapy IND work and downstream process development. Focuses on innovative therapeutics, biopharma supply chain and CGT.
Partner
Former senior investment banking professional at leading Chinese securities firms, with experience in IPOs, follow-on offerings, bond issuance and M&A / restructuring. B.A. and M.A. in Mathematics, University of Cambridge.
Insights
Static typed content in the first release, structured for future CMS integration.
AI4S
Static insight placeholder prepared for future CMS integration.
BD
A research framework around product rights, clinical milestones, commercial certainty and deal structure.
Founder transition
Reflecting FTEC's mission to grow with exceptional entrepreneurs over the long term.
Contact
Beijing · Shanghai | Email: contact@fte-capital.com (replace with official address)
The form separates financing, M&A, BD and other inquiries, with server-side validation, anti-spam checks and email forwarding.